4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-055586
CEO and Chairman sold 43,499 shares at an average $38.43 ($1,671,496)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-08 | Sale : show line 1 in the form | −11,742 | $38.34 | $450,188 | 1,705,218 | D |
| 2021-09-08 | Sale : show line 2 in the form | −2,004 | $39.11 | $78,376 | 1,703,214 | D |
| 2021-09-09 | Sale : show line 3 in the form | −24,753 | $38.42 | $951,010 | 1,678,461 | D |
| 2021-09-10 | Sale : show line 4 in the form | −4,902 | $38.37 | $188,090 | 1,673,559 | D |
| 2021-09-10 | Sale : show line 5 in the form | −98 | $39.09 | $3,831 | 1,673,461 | D |
| Open-market sales · 43,499 sh · avg $38.43 · $1,671,496 | ||||||
Loading xslF345X03/doc4.xml…